Symposium Speakers

Confirmed Symposium Speakers

Sexual contact networks, STI transmission and the effectiveness of interventions: Insights from mathematical modelling
Christian Althaus
University of Bern, Switzerland

Lessons learned from the pre-meeting symposium on characterizing the vaginal microbiota through a blinded multi-laboratory collaboration
Jen Balkus
University of Washington, USA

Global public health approaches to gonorrhea prevention and the threat of antibiotic resistance: Perspectives from Brazil and Latin America
Adele Schwartz Benzaken
Tropical Medicine Foundation, Manaus, Amazonas, Brazil

#SaveSexy: A gamified approach to harnessing the power of community activism for HIV testing promotion
Benedict Bernabe
Red Whistle, Philippines

Theoretical overview on methods including RCTs and other potential methodologies – advantages and disadvantages
Isolde Birdthistle
The London School of Hygiene & Tropical Medicine, London, UK

Resistance-guided therapy for M.genitalium: Impact of diagnostic resistance assays on practice and policy
Catriona Bradshaw
Central Clinical School, Monash University, Australia

Criminalisation of HIV transmission in the era of U=U
Michael Brady
Kings College Hospital/Terrence Higgins Trust, UK

The vaginal microenvironment prior to incident STI
Rebecca Brotman
University of Maryland School of Medicine, USA

Resurgent STIs in LMIC in reproductive age
Connie Celum
University of Washington, Seattle, USA

The role of oral-anal transmission in persistence of chlamydial infection
Henry de Vries
University of Amsterdam, Amsterdam, Netherlands

Point of care and home testing opportunities: Implications for quality public health practice
Patricia Dittus

Centers for Disease Control and Prevention, USA

The role of sexual networks in the global spread of antimicrobial-resistance enteric infections
Nigel Field
University College London, UK

JHU/USA – addressing medical dis- and mistrust
Errol Fields
Johns Hopkins University, USA

Use of whole genome sequencing to explore transmission between sexual networks in an STI outbreak
Helen Fifer
Public Health England,  London, UK

Youth and community based research
Sarah Flicker
York University, Canada

HPV self-collection in Peru
Application of a cascade approach for guiding prevention of congenital syphilis
Patricia Garcia
Universidad Peruana Cayetano Heredia, Lima, Peru

HPV based cervical screening: New evidence and current state of the art
Suzanne Garland
The Royal Women’s Hospital, Parkville, Australia

A tri-antigen protective syphilis vaccine design that enhances treponemal clearance and inhibits pathogen dissemination
Lorenzo Giacani
University of Washington, Seattle, USA

Working with community to control HIV/STI: A U.S. local health department perspective
Matthew Golden
University of Washington, Seattle, USA

CRISPR diagnostics: Expanding the nucleic acid detection toolbox by harnessing microbial diversity diagnosis
Jonathan Gootenberg
Massachusetts Institute of Technology, Cambridge, USA

HPTN 071 (PopART): Findings and lessons from a non-traditional RCT
Richard Hayes
The London School of Hygiene & Tropical Medicine, London, UK

Chemsex and new STI/HIV diagnoses among gay, bisexual and other men who have sex with men attending sexual health clinics
Aseel Hegazi
St George’s University Hospital Foundation Trust, London, UK

Evaluating complex public health issue violence – understanding and measuring violence and evaluating violence interventions – lessons from STRIVE
Lori Heise
Johns Hopkins University, Baltimore, USA

Does Azithromycin Have a Future in the Treatment of Gonorrhoea and Chlamydial Infection?
Anatomical Sites of Infection: Biomedical, Modeling, Behavioral, and Programmatic Considerations for STI Prevention: Biomedical Considerations
Jane Hocking
University of Melbourne, Melbourne, Australia

Home based testing: Unintended consequences and implications for antimicrobial stewardship – should we be concerned?
Paddy Horner
Population Health Sciences, University of Bristol, UK

Cervical cancer prevention in LMIC: Are we on the path to elimination?
Megan Huchko
Duke University, Durham, USA

Mobilising for health and rights: A history of sex worker activism in India
Smarajit Jana
Sonagachi Research and Training Institute, Kolkata, India

New approaches to STI diagnosis and prevention: Proteomics for T. pallidum
Chris Kenyon
Institute of Tropical Medicine, Antwerp, Belgium

Do rectal bacterial STIs in women matter? Who should we test and when?
Christine Khosropour
University of Washington, Seattle, USA

Implementing molecular testing to predict Neisseria gonorrhoeae susceptibility in clinical practice
Jeffrey D. Klausner
Fielding School of Public Health, USA

The relationship between demographics, health needs and the HIV care cascade outcomes: From infection to viral suppression
Abigail Kroch
Ontario HIV Treatment Network (OHTN), Canada

Reducing the global burden of infectious diseases through precision infection management (PIM)
Ian Lewis
University of Calgary, Calgary, Canada

Intersectionality, criminalisation and sexual health
Carmen Logie
University of Toronto, Canada

Therapeutic vaccination to treat HPV disease: Lessons learned from high grade intraepithelial lesions
Margaret Madeleine
Fred Hutchinson Cancer Research Center, USA

Gonorrhoea in EU/EEA – disease burden, key populations and antimicrobial resistance
Otilia Mårdh
European Centre for Disease Prevention and Control (ECDC), Solna, Sweden

Anatomical sites of infection: Biomedical, modeling, behavioral, and programmatic considerations for STI prevention
Programmatic considerations
Jeanne Marrazzo
University of Alabama, Birmingham, USA

Mobilization and empowerment of sex workers: Can self-help groups bring about sustained change? 
Primrose Matambanadzo
CeSHHAR, Zimbabwe

Sexual transmission of N. meningitidis in MSM and implications for public health
Anna McNulty
Sydney Sexual Health Centre, Australia

Anatomical sites of infection: Behavioural considerations for STI prevention
Catherine Mercer
University College London, UK

Improving the sexual and reproductive health of women living with HIV
Angelica Espinosa Miranda
Universidade Federal do Espirito Santo, Brazil

Treatment of bacterial vaginosis: How, when and how much?
Caroline Mitchell
Harvard University, Cambridge, USA

Prematurity and STI – value of screening and treatment
Deborah Money
University of British Columbia, Vancouver, Canada

Cascades and other approaches to guide PrEP programming
Sinead Delany-Moretlwe
Wits Reproductive Health and HIV Institute, Johannesburg, South Africa

Self-care interventions for sexual and reproductive health and rights
Manjulaa Narasimhan
World Health Organization, Geneva, Switzerland

An update on the status of HIV/STIs in IUSTI’s five regions
Francis Ndowa
Skin & GU Medicine Clinic, Harare, Zimbabwe

T. pallidum in vitro growth
Steven Norris
University of Texas, Houston, USA

Empowerment and approaches for stigma reduction: Implementation of HIV self-testing among female sex workers
Catherine Oldenburg
University of California, San Francisco, USA

Should enteric infections in MSM always be treated?
Mark Pakianathan
St George’s University Hospital Foundation Trust, London, UK

Pigtailed macaque model of STIs
Dorothy Patton
University of Washington, Seattle, USA

The health impacts of sex work criminalization: A review of the evidence
Lucy Platt
The London School of Hygiene & Tropical Medicine, London, UK

Using multiple data sources for programme evaluation: Integration of program monitoring data with other research studies
BM Ramesh
University of Manitoba, Winnipeg, Canada

Authentic and successful community engagement for STI/HIV prevention, screening, and treatment in rural and urban setting
Scott Rhodes
University of North Carolina, USA

Screening women for bacterial STIs: Should we scale back?
Jonathan Ross
University of Birmingham, Birmingham, UK

Engaging culturally and linguistically diverse populations in HIV/STI services: Challenges and opportunities
Shailendra Sawleshwarkar
University of Sydney, Australia

Global public health approaches to gonorrhea prevention and the threat of antibiotic resistance: Perspectives from North America
Karen Schlanger
Center for Disease Control and Prevention, Atlanta, USA

Challenges in defining Chemsex. Answers for surveillance from EMIS-2017
Axel J. Schmidt
London School of Hygiene and Tropical Medicine, London, UK

Hepatitis C in HIV-negative MSM – a growing concern?
Axel J. Schmidt
London School of Hygiene and Tropical Medicine, London, UK

Progress towards a gonorrhea vaccine
Kate Seib
Griffith University, Brisbane, Australia

Applications of the HIV prevention cascade framework in work evaluating the DREAMS programme
HIV self-testing at the STAR project
Maryam Shahmanesh
London’s Global University, London, UK

Global public health approaches to gonorrhea prevention and the threat of antibiotic resistance: Perspectives from Thailand and Asia
Pachara Sirivongrangson
Department of Disease Control, Thailand Ministry of Public Health, Nonthaburi, Thailand

Understanding how laws and policies affect HIV prevention practices: A theoretical approach
Morten Skovdal
University of Copenhagen, Denmark

Modeling considerations related to multi-site infection
Ian Spicknall
Centers for Disease Control and Prevention, Atlanta, USA

A mucosal Chlamydia trachomatis vaccine stimulates protective memory T cells
Michael Starnbach
Harvard Medical School, Cambridge, USA

Use of cervical explants to dtudy gonococcal pathogenesis
Daniel Stein
University of Maryland, College Park, USA

Spurring innovation in improving community engagement for STI prevention
Weiming Tang
University of North Carolina Project-China, China

HPV vaccination in MSM: Who should be vaccinated and is there a role for vaccination of older and/or HIV-positive MSM in preventing initial, persistent and recurrent HPV and related diseases?
David Templeton
University of Sydney, Australia

Maximizing the acceptability, feasibility and validity of sexual network studies: Lessons from the field 
Abigail Norris Turner
Ohio State University, Ohio, USA

The North American overdose crisis: How structural violence, prohibition and stigma have paralyzed our response
Mark Tyndall
BC Centre for Disease Control, Vancouver, Canada

Role of the genital tract microbiome in sexual and reproductive health: Report from the Keystone Symposium in Cape Town, 2018
Janneke van de Wijgert
University of Liverpool, UK and University Medical Center Utrecht, The Netherlands

Chlamydia trachomatis, Trichomonas vaginalis and Treponema pallidum infections in macaques: Effects on simian HIV acquisition 
Sundaram Ajay Vishwanathan
Center for Disease Control and Prevention, Atlanta, USA

Syphilis self-testing: A nationwide pragmatic study among men who have sex with men in China
Cheng Wang
Southern Medical University, Guangzhou, China

Impact of HIV PrEP on risk compensation and STI epidemiology – what does the evidence show?
Helen Ward
Imperial College London, UK

Bridging the gap – best practice global examples of integration of HIV and STI services
Janet Wilson
National Health Service, UK

New approaches to STI diagnosis and prevention: Combatting HIV with nanomaterials
Kim Woodrow
University of Washington, Seattle, USA

Building STD clinical infrastructure in LMIC – role of general vs. specialized infrastructure
Ligang Yang
Southern Medical University, Guangzhou, China

Congress Newsletter


Subscribe to the Newsletter to receive important information about the upcoming congress.